Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCOS-COMBO: Metformin, Inositol, Diet, and Combination Therapy in PCOS
NCT07380841Completed
- Sponsor
- Islamabad Medical and Dental College
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of liquid metformin (Aspargo Labs) and myo-inositol in polycystic ovary syndrome (PCOS) (4 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: Change in insulin resistance (HOMA-IR) at 12 weeks. Started May 2025; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)myo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07380841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07380841.